【数据看盘】多只创新药概念股获机构加仓游资、量化激烈博弈西藏天路

市场资讯2025-07-29

炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！　　沪深股通今日合计成交2334.31亿，其中恒瑞医药和宁德时代分居沪股通和深股通个股成交额首位。板块主力资金方面，医药板块主力资金净流入居首。ETF成交方面，港股通创新药（520880）成交额环比增长251%。期指持仓方面，IH合约空头减仓数量明显大于多头。龙虎榜方面，北方长龙获机构买入1.17亿；德科立获机构买入1.8亿...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2555037695?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-07-29 18:16","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2555037695","market":"hk","top_or_hot":-1,"title":"【数据看盘】多只创新药概念股获机构加仓 游资、量化激烈博弈西藏天路","media":"市场资讯","content":"<div>\n<p>炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　沪深股通今日合计成交2334.31亿，其中恒瑞医药和宁德时代分居沪股通和深股通个股成交额首位。板块主力资金方面，医药板块主力资金净流入居首。ETF成交方面，港股通创新药（520880）成交额环比增长251%。期指持仓方面，IH合约空头减仓数量明显大于多头。龙虎榜方面，北方长龙获机构买入1.17亿；德科立获机构买入1.8亿...</p>\n\n<a href=\"https://finance.sina.com.cn/jjxw/2025-07-29/doc-inficsmt4692131.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>【数据看盘】多只创新药概念股获机构加仓 游资、量化激烈博弈西藏天路</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n【数据看盘】多只创新药概念股获机构加仓 游资、量化激烈博弈西藏天路\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-07-29 18:16 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/jjxw/2025-07-29/doc-inficsmt4692131.shtml><strong>市场资讯</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　沪深股通今日合计成交2334.31亿，其中恒瑞医药和宁德时代分居沪股通和深股通个股成交额首位。板块主力资金方面，医药板块主力资金净流入居首。ETF成交方面，港股通创新药（520880）成交额环比增长251%。期指持仓方面，IH合约空头减仓数量明显大于多头。龙虎榜方面，北方长龙获机构买入1.17亿；德科立获机构买入1.8亿...</p>\n\n<a href=\"https://finance.sina.com.cn/jjxw/2025-07-29/doc-inficsmt4692131.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0235","symbol_name":"非金矿物","start_time":0,"source_url":"https://finance.sina.com.cn/jjxw/2025-07-29/doc-inficsmt4692131.shtml","article_id":"2555037695","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2555037695","pubTimestamp":1753784160,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"　　沪深股通今日合计成交2334.31亿，其中恒瑞医药和宁德时代分居沪股通和深股通个股成交额首位。板块主力资金方面，医药板块主力资金净流入居首。期指持仓方面，IH合约空头减仓数量明显大于多头。龙虎榜方面，北方长龙获机构买入1.17亿；德科立获机构买入1.8亿；上海电影遭机构卖出超7000万；爱婴室遭机构卖出超4000万；云南锗业获国泰海通南京太平南路营业部净买入1.02亿；硕贝德遭一家量化席位卖出1亿。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"159992":"创新药","600326":"西藏天路","BK0235":"非金矿物","BK0101":"PPP","BK0188":"融资融券","BK1161":"生物科技","BK1574":"生物医药B类股","06978":"永泰生物-B","BK0139":"涉矿","BK0033":"西藏振兴"},"translate_title":"[Data viewing] A number of innovative drug concept stocks have received hot money from institutions to increase their positions, and fierce quantitative game in Tibet Tianlu","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"159992":1,"600326":1,"06978":1},"content_text":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 　　沪深股通今日合计成交2334.31亿，其中恒瑞医药和宁德时代分居沪股通和深股通个股成交额首位。板块主力资金方面，医药板块主力资金净流入居首。ETF成交方面，港股通创新药（520880）成交额环比增长251%。期指持仓方面，IH合约空头减仓数量明显大于多头。龙虎榜方面，北方长龙获机构买入1.17亿；德科立获机构买入1.8亿；上海电影遭机构卖出超7000万；爱婴室遭机构卖出超4000万；云南锗业获国泰海通南京太平南路营业部净买入1.02亿；硕贝德遭一家量化席位卖出1亿。\n　　一、沪深股通前十大成交\n　　今日沪股通总成交金额为1202.32亿，深股通总成交金额为1131.99亿。\n\n　　从沪股通前十大成交个股来看，恒瑞医药位居首位；药明康德和贵州茅台分居二、三位。\n　　从深股通前十大成交个股来看，宁德时代位居首位；中际旭创和分居胜宏科技二、三位。\n　　二、板块个股主力大单资金\n　　从板块表现来看，CRO、钢铁、CPO、先进封装等板块涨幅居前，保险、猪肉、银行、农业等板块跌幅居前。\n\n　　从主力板块资金监控数据来看，医药板块主力资金净流入居首。\n　　板块资金流出方面，有色金属板块主力资金净流出居首。\n\n　　从个股主力资金监控数据来看，主力资金净流入前十的个股所属板块较为杂乱，新易盛净流入居首。\n　　主力资金流出前十的个股所属板块较为杂乱，孩子王净流出居首。\n　　三、ETF成交\n\n　　从成交额前十的ETF来看，香港证券ETF（513090）成交额位居首位，港股创新药ETF（513120）成交额位居次席。\n\n　　从成交额环比增长前十的ETF来看，多只港股医药和科技相关ETF成交额大增，其中港股通创新药（520880）成交额环比增长251%位居首位。\n　　四、期指持仓\n\n　　四大期指主力合约多空双方均减仓，且空头减仓数量均大于多头，其中IH合约空头减仓数量明显大于多头。\n　　五、龙虎榜\n　　1、机构\n\n　　今日龙虎榜机构活跃度较高，买入方面，军工股北方长龙获机构买入1.17亿；创新药概念股众生药业获机构买入1.37亿，睿智医药、南新制药均获机构买入超8000万；CPO概念股德科立获机构买入1.8亿。\n　　卖出方面，上海电影遭机构卖出超7000万；爱婴室遭机构卖出超4000万。\n　　2、游资\n\n　　一线游资活跃度较低，超级水电概念股西藏天路获国投证券西安朱雀大街营业部净买入1.1亿，同时遭国泰海通南京太平南路营业部净卖出1.33亿；云南锗业获国泰海通南京太平南路营业部净买入1.02亿。\n\n　　量化资金活跃度有所下降，西藏天路获一家量化席位买入超9000万，同时遭一家量化席位卖出1.06亿；硕贝德遭一家量化席位卖出1亿。\n新浪声明：此消息系转载自新浪合作媒体，新浪网登载此文出于传递更多信息之目的，并不意味着赞同其观点或证实其描述。文章内容仅供参考，不构成投资建议。投资者据此操作，风险自担。\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张恒星","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":false,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2555037695","isCrawlerRequest":true}

【数据看盘】多只创新药概念股获机构加仓 游资、量化激烈博弈西藏天路

精彩评论

【数据看盘】多只创新药概念股获机构加仓游资、量化激烈博弈西藏天路